An interventional study of SMS and email reminders and Proactive conversational AI voice calls in Shoulder Arthroplasty, Patient Reported Outcome Measures and Shoulder Pain, sponsored by Institut de Chirurgie Reparatrice Locomoteur et Sports. Recruiting at 4 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Institut de Chirurgie Reparatrice Locomoteur et Sports · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
After shoulder replacement surgery, surgeons send questionnaires to their patients to learn how they are doing (pain, shoulder function, satisfaction). Many patients do not answer. This study tests the best way to obtain these answers.
The study is nested in a multicenter study of pain after shoulder arthroplasty conducted in four French centers (host study RetroPAinRSACAll, supported by Ramsay Santé). The clinical results of the host study are not the subject of this registration: this study evaluates only the method used to collect the information.
All patients first receive an email invitation (when an email address is available) and, the next day, a text message (SMS) with a personal link to the questionnaire and a phone number to answer at any time by talking with an automated voice assistant. Patients who have not answered two days after the first contact are randomly assigned to one of two follow-up strategies: (1) further digital reminders (SMS on day 3 and day 5, email on day 7), or (2) up to three phone calls from a conversational artificial intelligence (AI) voice agent on days 3, 5 and 7, which asks the same questions orally. In both groups, patients can answer at any time online or by calling the voice assistant, and contacts stop as soon as the questionnaire is completed or the patient refuses.
The main outcome is the proportion of patients who complete the questionnaire within 14 days of the first contact.
Design. VOICE-REACH is a pragmatic, multicenter, individually randomized, two-arm, open-label superiority study within a trial (SWAT). It is embedded in the host study RetroPAinRSACAll (persistent pain after shoulder arthroplasty, four French shoulder surgery centers, favorable opinion of the Ramsay Santé scientific committee, reference COS-RGDS-2026-07-008). All patients of the host cohort are contacted through the DeepCall platform on behalf of their surgeon to complete the host study questionnaire (operation details, warning signs, pain screening and characterization, rehabilitation and function including the Subjective Shoulder Value, opinion on the operation and on the contact). The comparison concerns the follow-up strategy only: the questionnaire is the same in both arms and the same on the web and by voice.
Common phase (all participants). Day 0: email invitation with a personal questionnaire link, sent when an email address is available. Day 1: SMS with the same link, the phone number of the AI voice agent (available 24 hours a day for inbound calls) and an opt-out option (reply NO). Patients are contacted in successive waves of up to 450 patients, one day apart, to respect operator sending limits; all study days are counted from each participant's own day 0.
Randomization. On day 2, participants who have not completed the questionnaire and have not refused are randomized 1:1 by the platform, using a computer-generated permuted block sequence (blocks of 4) stratified by center. Participants who completed the questionnaire before day 2 are not randomized and are described separately.
Arm A, digital reminders: SMS reminders on day 3 and day 5 and an email reminder on day 7 (when an email address is available).
Arm B, proactive AI calls: outbound calls from the AI voice agent on day 3, day 5 and day 7 (up to three attempts). The agent calls on behalf of the surgeon's team and asks the questionnaire orally; answers are extracted into the same structured fields as the web form.
In both arms, the web link and the inbound voice line remain available throughout, and all scheduled contacts stop as soon as the questionnaire is completed, the patient refuses, or the patient is identified as deceased. Warning signs reported by patients are flagged to the surgical team for review; the AI agent does not give medical advice.
Analysis. The primary analysis is intention to treat among all randomized participants: proportion with a completed questionnaire by day 14, risk difference (Arm B minus Arm A) with 95% confidence interval, adjusted for center and email availability. Participants without a completed questionnaire by day 14 are counted as non-completers; no answer is imputed. Secondary analyses describe the yield of the common phase, time to completion, completion channel, partial responses, refusals, number of contacts and cost per completed questionnaire, acceptability of the contact mode among responders, representativeness of responders, and the accuracy of voice-captured answers.
Registration timing. The common pre-randomization outreach started on 9 November 2026. This record was created on 10 November 2026, before the first randomization (day 2 of the first wave, 11 November 2026).
736 studies on the registry are indexed under Shoulder Pain; 166 are open to participants now.
This study's planned enrollment of 846 is above the median of 60 across 588 interventional studies indexed under Shoulder Pain.
Browse Shoulder Pain studies →Institut de Chirurgie Reparatrice Locomoteur et Sports is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Additional criteria for randomization (day 2):
* Questionnaire not completed and no refusal at the day-2 cutoff
Exclusion Criteria:
Common phase: email invitation on day 0 (if an email address is available) and SMS invitation on day 1 with the questionnaire link and the AI voice agent phone number. After randomization on day 2: SMS reminder on day 3, SMS reminder on day 5 and email reminder on day 7 (if an email address is available). Participants can answer at any time by web link or by calling the AI voice agent. Contacts stop at completion or refusal.
Behavioral: SMS and email reminders
Same common phase (email on day 0 if available, SMS on day 1). After randomization on day 2: up to three outbound calls from the conversational AI voice agent on day 3, day 5 and day 7, during which the same questionnaire is asked orally. Participants can also answer at any time by web link or by calling the AI voice agent. Contacts stop at completion or refusal.
Behavioral: Proactive conversational AI voice calls
Standardized reminder messages sent by the DeepCall platform on behalf of the surgeon: SMS on day 3 and day 5 and email on day 7 (if an email address is available), each with the personal questionnaire link, the AI voice agent phone number and an opt-out option.
Outbound telephone calls placed by a conversational AI voice agent (DeepCall platform) on day 3, day 5 and day 7, up to three attempts. The agent calls on behalf of the surgeon's team, conducts the same questionnaire orally and records the answers in the same structured fields as the web form.
Also known as: DeepCall
Questionnaire Completion by Day 14 Among Randomized Participants
Proportion of randomized participants with a completed questionnaire within 14 days of their first contact (day 0), whatever the channel used (web link, inbound call or outbound AI call). A questionnaire is complete when it was submitted on the web or when all required items were answered during a voice interview. Participants without a completed questionnaire at the day-14 cutoff are counted as non-completers. Compared between arms (proactive AI voice calls minus digital reminders).
Time frame: From day 0 (first contact) to day 14
Questionnaire Completion by Day 7 Among Randomized Participants
Proportion of randomized participants with a completed questionnaire by day 7, whatever the channel used.
Time frame: From day 0 to day 7
Time to Questionnaire Completion
Time in hours from randomization (day 2) to questionnaire completion among randomized participants; participants without a completed questionnaire are censored at day 14.
Time frame: From day 2 to day 14
Questionnaire Completion Before Randomization
Proportion of all enrolled participants who completed the questionnaire after the common email (day 0) and SMS (day 1) invitations, before the day-2 randomization.
Time frame: From day 0 to day 2
Questionnaire Completion by Day 14 in All Enrolled Participants
Proportion of all enrolled participants, randomized or not, with a completed questionnaire by day 14.
Time frame: From day 0 to day 14
Partial Questionnaire Response
Proportion of randomized participants who answered at least one question without completing the questionnaire by day 14.
Time frame: From day 0 to day 14
Completion Channel
Distribution of completed questionnaires by channel (web link, inbound call to the voice agent, outbound AI call), by arm.
Time frame: From day 0 to day 14
Refusal of Contact
Proportion of randomized participants who explicitly refused further contact (SMS reply, email refusal link or refusal during a call).
Time frame: From day 2 to day 14
Number of Contacts per Completed Questionnaire
Number of emails, SMS and outbound calls sent or attempted, divided by the number of completed questionnaires, by arm.
Time frame: From day 0 to day 14
Direct Cost per Completed Questionnaire
Direct costs of messaging, telephony and AI processing (euros) divided by the number of completed questionnaires, by arm, and incremental cost per additional completed questionnaire.
Time frame: From day 0 to day 14
Satisfaction With the Mode of Contact
Among participants who completed the questionnaire: satisfaction with the way they were contacted, rated on a 5-level scale from very satisfied to very dissatisfied.
Time frame: From day 0 to day 14
Perceived Number of Contacts
Among participants who completed the questionnaire: perceived number of contacts (too many, appropriate, too few).
Time frame: From day 0 to day 14
Preferred Contact Mode for Future Follow-up
Among participants who completed the questionnaire: preferred mode of contact for future follow-up questionnaires (categorical).
Time frame: From day 0 to day 14
Characteristics of Responders Versus Non-Responders
Age, center, type of arthroplasty and time since surgery (when available in the host cohort) compared between participants who completed the questionnaire and those who did not, by arm (standardized differences).
Time frame: Day 14
Agreement Between Voice-Captured Answers and Human Review
In a random sample of completed voice interviews, agreement between the answers extracted by the AI agent and those coded by a reviewer listening to the recording, blinded to the extracted values (percentage agreement, kappa or intraclass correlation coefficient).
Time frame: From day 0 to day 14
Delivery of Email and SMS Invitations
Proportion of emails and SMS delivered, bounced or filtered by the operator, as reported by the sending providers.
Time frame: From day 0 to day 7
Outbound Call Outcomes
Distribution of outbound AI call outcomes (answered, voicemail, no answer, filtered, failed) and call duration in the proactive AI voice calls arm.
Time frame: From day 3 to day 7
Plan to share: No — Identifiable data, call recordings and transcripts will not be shared. Aggregated results will be published.
No publications or documents are linked to this record.
Started Nov 2026 (actual). Primary completion is estimated for Nov 2026, 0 months after the start.
Of 350 non-industry interventional studies with no phase under Shoulder Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's planned 0 months is below that.
Counting every sponsor, half of 355 studies reached it within 11 months; a quarter within 4 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut de Chirurgie Reparatrice Locomoteur et Sports